Sequential chemotherapy with capecitabine and irinotecan followed by capecitabine and oxaliplatin in elderly vulnerable patients (pts) with metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Cupini, S. [1 ]
Bursi, S. [1 ]
Masi, G. [1 ]
Loupakis, F. [1 ]
Barbara, C. [1 ]
Barletta, M. T. [1 ]
Baldi, G. G. [1 ]
Vasile, E. [1 ]
Fornaro, L. [1 ]
Petrini, I. [2 ]
Allegrini, G. [1 ]
Antonuzzo, A. [1 ]
Di Marsico, R. [1 ]
Andreuccetti, M. [1 ]
Ricci, S. [2 ]
Falcone, A. [1 ,3 ]
机构：
[1] Azienda USL 6, Div Med Oncol, Livorno, Italy
[2] Santa Chiara Hosp, Div Med Oncol, Pisa, Italy
[3] Univ Pisa, I-56100 Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Phase II trial of sequential chemotherapy with capecitabine and irinotecan followed by capecitabine and oxaliplatin in elderly vulnerable patients (pts) with metastatic colorectal cancer (MCRC)
    Cupini, S.
    Bursi, S.
    Masi, G.
    Loupakis, F.
    Barbara, C.
    Fornaro, L.
    Allegrini, G.
    Di Marsico, R.
    Andreuccetti, M.
    Falcone, A.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 251 - 251
  • [2] EFFICACY AND SAFETY OF CAPECITABINE AND IRINOTECAN (CAPIRI) IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, Adda
    Smaili, Farida
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v99 - v99
  • [3] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST - LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Adda, B.
    Farida, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [4] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST -LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, A.
    Smail, F.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 67 - 68
  • [5] Phase II study of capecitabine plus oxaliplatin (XELOX) followed by capecitabine plus irinotecan (XELIRI) in a sequential schedule in first-line metastatic colorectal cancer (MCRC)
    Cassinello, Javier
    Alvarez, Jose V.
    Garcia Lopez, Maria J.
    Pujol, Eduardo
    Colmenarejo, Antonio
    De Segovia, Fernando
    Marcos, Fernando
    Filipovich, Elena
    Arcediano, Alberto
    Garcia Castro, Ines
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 116 - 117
  • [6] Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)
    Salud, A.
    Escudero, P.
    Feliu, J.
    Lopez-Gomez, L.
    Bolanos, M.
    Galan, A.
    Yubero, A.
    Vicent, J. M.
    Losa, F.
    Gonzalez-Baron, M.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 190 - 190
  • [7] CAPECITABINE AND IRINOTECAN AS FIRSTLINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    [J]. JOURNAL OF IMAB, 2010, 16 (03): : 74 - 77
  • [8] XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC).
    López-Gómez, L
    Escudero, P
    Yubero, A
    Feliú, J
    Salud, A
    Galán, A
    Bolaños, M
    Vicent, JM
    Losa, F
    González-Barón, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 291S - 291S
  • [9] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (Pts) with metastatic colorectal cancer (MCRC)
    Laudani, A.
    Savio, G.
    Leonardi, V.
    Palmisano, V.
    Tartaglia, L.
    Manuguerra, G.
    Pepe, A.
    Alu, M.
    Usset, A.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 6 - 6
  • [10] Preliminary data on weekly irinotecan (CPT) with continuous capecitabine (X) in metastatic colorectal cancer (MCRC) patients (pts).
    Anderson, N
    Lokich, J
    Kalman, L
    Bertoli, L
    Foulke, R
    Ratner, L
    Weitberg, A
    Burris, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 307S - 307S
12345